GlassScriptPhysician profile
Paul H Chiu
NPI 1467440883
$6,007.19
in general payments reported to CMS, 2019-2025
35 companies · $1,676 in 2025
The $1,676 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $352 · 2020: $398 · 2021: $616 · 2022: $732 · 2023: $1,116 · 2024: $1,116 · 2025: $1,676.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,445 · Travel and Lodging: $464.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,444.57 |
| Travel and Lodging | $464.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $832.76 | 2019-2025 | Wavewriter Alpha Prime 16, Superion Indirect Decompression System, Intracept |
| Medtronic, INC. | $735.69 | 2021-2024 | Intellis Adaptivestim |
| Forte Bio-Pharma LLC | $657.17 | 2022-2025 | Prolate, Nalocet, Tanlor |
| Curonix LLC | $533.02 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Virtus Pharmaceuticals LLC | $333.69 | 2021-2025 | Levorphanol Tartrate |
| Collegium Pharmaceutical, INC. | $313.59 | 2023-2025 | Belbuca |
| Biotronik Nro, INC. | $293.58 | 2023-2025 | Prospera, Biotronik |
| Abbott Laboratories | $257.51 | 2019-2025 | Proclaim, Eterna |
| Almatica Pharma LLC | $240.63 | 2021-2022 | |
| Painteq LLC | $235.36 | 2022-2023 | Painteq |
| Spr Therapeutics, INC | $168.38 | 2023-2025 | Sprint Pns System |
| Saluda Medical Americas, INC. | $167.76 | 2024-2025 | Evoke |
| Spinal Simplicity, LLC | $163.21 | 2022-2025 | Ha Minuteman G3-R |
| Biodelivery Sciences International, INC. | $128.33 | 2019-2021 | |
| Foundation Fusion Solutions, LLC | $110.41 | 2023-2024 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $99.37 | 2021-2022 | |
| Vertex Pharmaceuticals Incorporated | $93.72 | 2025 | |
| Redhill Biopharma INC. | $87.75 | 2020-2021 | |
| Pfizer INC. | $86.22 | 2020-2021 | |
| Vertiflex, INC. | $74.62 | 2019 | |
| Bioventus LLC | $52.39 | 2022 | |
| Stimwave Technologies Incorporated | $44.38 | 2019-2021 | |
| Si-Bone, INC. | $44.10 | 2024-2025 | |
| Vertos Medical, INC. | $35.63 | 2020 | |
| Scilex Pharmaceuticals INC. | $28.46 | 2019 | |
| Sentynl Therapeutics, INC. | $26.13 | 2019 | |
| Fidia Pharma USA INC. | $24.40 | 2022 | |
| Mml US, INC. | $23.34 | 2025 | Reactiv8 |
| Zimmer Biomet Holdings, INC. | $22.25 | 2025 | Gel-One Cross-Linked Hyaluronate |
| Avanos Medical | $19.49 | 2023 | Genvisc 850 Sodium Hyaluronate |
| Arbor Pharmaceuticals, INC. | $19.39 | 2019 | |
| Genentech USA, INC. | $17.54 | 2019 | |
| Nalu Medical, INC. | $13.76 | 2023 | Nalu Neurostimulation System |
| Relievant Medsystems, INC. | $11.91 | 2021 | |
| Nevro Corp. | $11.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Chiu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.